Impact Factor 3.831

Frontiers journals are at the top of citation and impact metrics

General Commentary ARTICLE

Front. Pharmacol., 28 June 2017 | https://doi.org/10.3389/fphar.2017.00427

Expression of Concern: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

With this notice, Frontiers states its awareness of serious allegations surrounding the article “Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze” published on 5 May 2017. Our Chief Editors will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.

Citation: Frontiers Editorial Office (2017) Expression of Concern: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze. Front. Pharmacol. 8:427. doi: 10.3389/fphar.2017.00427

Received: 14 June 2017; Accepted: 14 June 2017;
Published: 28 June 2017.

Edited and reviewed by: Théophile Godfraind, Université Catholique de Louvain, Belgium

Copyright © 2017 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org